Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Cirrhosis

  Free Subscription


22.08.2022

1 Dig Dis Sci
2 Gut
2 Hepatology
1 J Hepatol
1 PLoS One
2 Transplant Proc
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Dig Dis Sci

  1. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    PubMed         Abstract available


    Gut

  2. HUNG CT, Su TH, Chen YT, Wu YF, et al
    Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFbeta signalling.
    Gut. 2021 Dec 21. pii: gutjnl-2021-325065. doi: 10.1136/gutjnl-2021-325065.
    PubMed         Abstract available

  3. SIMON TG, Roelstraete B, Hagstrom H, Sundstrom J, et al
    Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Gut. 2022;71:1867-1875.
    PubMed         Abstract available


    Hepatology

  4. SERPER M, Kaplan DE, Taddei TH, Tapper EB, et al
    Non-selective Beta Blockers, Hepatic Decompensation and Mortality in Cirrhosis: A National Cohort Study.
    Hepatology. 2022 Aug 19. doi: 10.1002/hep.32737.
    PubMed         Abstract available

  5. LOUREIRO D, Tout I, Narguet S, Bed CM, et al
    Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C or nonalcoholic steatohepatitis.
    Hepatology. 2022 Aug 16. doi: 10.1002/hep.32731.
    PubMed         Abstract available


    J Hepatol

  6. DEGASPERI E, Anolli MP, Uceda Renteria SC, Sambarino D, et al
    Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension.
    J Hepatol. 2022 Aug 13. pii: S0168-8278(22)02980.
    PubMed         Abstract available


    PLoS One

  7. LU YH, Lu CK, Chen CH, Hsieh YY, et al
    Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting.
    PLoS One. 2022;17:e0272567.
    PubMed         Abstract available


    Transplant Proc

  8. JANUSZKO-GIERGIELEWICZ B, Kobryn A, Donderski R, Trzcinska J, et al
    Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review.
    Transplant Proc. 2022 Jun 24. pii: S0041-1345(22)00318.
    PubMed         Abstract available

  9. MIKOLAJCZYK-KORNIAK N, Baczkowska T, Tronina O, Durlik M, et al
    Noninvasive Diagnostic Methods for the Assessment of Hepatic Fibrosis in Liver Transplant Recipients.
    Transplant Proc. 2022 Jun 2. pii: S0041-1345(22)00185.
    PubMed         Abstract available


    Z Gastroenterol

  10. DIETRICH CF, Shi L, Lowe A, Dong Y, et al
    Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.
    Z Gastroenterol. 2022;60:1235-1248.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: